Contrast Agent Market - Forecasts from 2019 to 2024
The global contrast agent market is projected to grow at a CAGR of 9.45% to reach US$9.739 billion by 2024, from US$5.664 billion in 2018. Contrast agents or contrast media are the dyes used to view or highlight specific organs, tissues or blood vessels for the radiological diagnosis or to determine the extent of any diseases or injury. Once the contrast is administered in the body, it quickly circulates throughout the body highlighting the specific tissue or organ to be observed, with kidneys and liver quickly eliminate the contrast from the body at the end.
The market is expected to show robust growth during the forecast period which may be attributed to the growing number of diagnostic procedures due to the rising burden of chronic diseases and traumatic injuries across the globe. Technological advancements in contrast media such as the development of microbubbles/ microsphere contrast agents will also boost the growth of the market during the forecast period. However, adverse effects associated with the contrast agents coupled with the stringent regulatory requirements for the market approval of contrast media might hamper the growth of the market during the given time frame.
The Contrast Agent Market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, modality, route of administration, end-user, and geography.
Based on type, the market has been segmented as Iodine Based, Barium Based and Gadolinium Based. On the basis of modality, the market is segmented as X-Ray, MRI, CT, and Ultrasound. By route of administration, the market is segmented as intravenous, oral and rectal. Based on End-Users, the market has been segmented as Hospitals and Clinics, Ambulatory Care Centres and Diagnostic labs.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the contrast agent market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the contrast agent market.
Segmentation:
The market is expected to show robust growth during the forecast period which may be attributed to the growing number of diagnostic procedures due to the rising burden of chronic diseases and traumatic injuries across the globe. Technological advancements in contrast media such as the development of microbubbles/ microsphere contrast agents will also boost the growth of the market during the forecast period. However, adverse effects associated with the contrast agents coupled with the stringent regulatory requirements for the market approval of contrast media might hamper the growth of the market during the given time frame.
The Contrast Agent Market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, modality, route of administration, end-user, and geography.
Based on type, the market has been segmented as Iodine Based, Barium Based and Gadolinium Based. On the basis of modality, the market is segmented as X-Ray, MRI, CT, and Ultrasound. By route of administration, the market is segmented as intravenous, oral and rectal. Based on End-Users, the market has been segmented as Hospitals and Clinics, Ambulatory Care Centres and Diagnostic labs.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the contrast agent market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the contrast agent market.
Segmentation:
- By type
- Iodine Based
- Barium Based
- Gadolinium Based
- Modality
- X-Ray
- MRI
- CT
- Ultrasound
- Route of Administration
- Intravenous
- Oral
- Rectal
- End-user
- Hospitals & Clinics
- Ambulatory Care Centres
- Diagnostic labs
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- Italy
- Spain
- Others
- Middle East and Africa (MEA)
- Israel
- Saudi Arabia
- Other
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. CONTRAST AGENT MARKET BY TYPE
5.1. Iodine Based
5.2. Barium Based
5.3. Gadolinium Based
6. CONTRAST AGENT MARKET BY MODALITY
6.1. X-Ray
6.2. MRI
6.3. CT
6.4. Ultrasound
7. CONTRAST AGENT MARKET BY ROUTE OF ADMINISTRATION
7.1. Intravenous
7.2. Oral
7.3. Rectal
8. CONTRAST AGENT MARKET BY END USERS
8.1. Hospitals & Clinics
8.2. Ambulatory Care Centres
8.3. Diagnostic labs
9. CONTRAST AGENT MARKET BY GEOGRAPHY
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. UK
9.3.2. Germany
9.3.3. Italy
9.3.4. Spain
9.3.5. Others
9.4. Middle East and Africa
9.4.1. Israel
9.4.2. Saudi Arabia
9.4.3. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. Australia
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Competitive Benchmarking and Analysis
10.2. Strategies of Key Players
10.3. Recent Investments and Deals
11. COMPANY PROFILE
11.1. Guerbet Group
11.2. Bracco Imaging Pharmaceutical Sterile Operations GmbH
11.3. Bayer HealthCare
11.4. Lantheus Medical Imaging, Inc
11.5. Tide Microfluidics
11.6. Novalek Pharmaceuticals Pvt. Ltd
11.7. FUJIFILM VisualSonics Inc.
11.8. Ferric Contrast, Inc.
11.9. Daiichi Sankyo Company, Limited.
11.10. Magnus Health
List of Figures
List of Tables
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. CONTRAST AGENT MARKET BY TYPE
5.1. Iodine Based
5.2. Barium Based
5.3. Gadolinium Based
6. CONTRAST AGENT MARKET BY MODALITY
6.1. X-Ray
6.2. MRI
6.3. CT
6.4. Ultrasound
7. CONTRAST AGENT MARKET BY ROUTE OF ADMINISTRATION
7.1. Intravenous
7.2. Oral
7.3. Rectal
8. CONTRAST AGENT MARKET BY END USERS
8.1. Hospitals & Clinics
8.2. Ambulatory Care Centres
8.3. Diagnostic labs
9. CONTRAST AGENT MARKET BY GEOGRAPHY
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. UK
9.3.2. Germany
9.3.3. Italy
9.3.4. Spain
9.3.5. Others
9.4. Middle East and Africa
9.4.1. Israel
9.4.2. Saudi Arabia
9.4.3. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. Australia
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Competitive Benchmarking and Analysis
10.2. Strategies of Key Players
10.3. Recent Investments and Deals
11. COMPANY PROFILE
11.1. Guerbet Group
11.2. Bracco Imaging Pharmaceutical Sterile Operations GmbH
11.3. Bayer HealthCare
11.4. Lantheus Medical Imaging, Inc
11.5. Tide Microfluidics
11.6. Novalek Pharmaceuticals Pvt. Ltd
11.7. FUJIFILM VisualSonics Inc.
11.8. Ferric Contrast, Inc.
11.9. Daiichi Sankyo Company, Limited.
11.10. Magnus Health
List of Figures
List of Tables
